CRISPR AND CAS GENE MARKET ANALYSIS

Crispr and Cas Gene Market, By Product Type (Vector-based Cas, DNA-free Cas, and Others), By Application (Genome Engineering, Disease Models, Functional Genomics, Knockdown/Activation, and Others), By End User (Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023
Code : CMI2598
Pages :165
Formats :
Excel and PDF
Industry : Biotechnology

Crispr And Cas Gene MarketSize and Trends

The global crispr and cas gene market is estimated to be valued at US$ 1.54 Billion in 2023 and is expected to exhibit a CAGR of 22.8 % during the forecast period (2023-2030).

For instance, on April 27, 2023, a team of University of Florida researchers developed a promising new CRISPR-powered method for non-invasive blood tests that could help clinicians diagnose cancer at earlier stages.

Global Crispr and Cas Gene Market - Cross Sectional Analysis:

Key players are focusing on inorganics strategies, such as collaborations, for the development of products is expected to drive the market growth over the forecast period.